Delstrigo, Filmtabletten - 30 Swissmedic Key 67066001 Registration Holder MSD Merck Sharp & Dohme AG Name Delstrigo, Filmtabletten Date of registration 17.12.2019 Introduction of Sequence 17.12.2019 ATC-Classification Lamivudine, Tenofovir Disoproxil and Doravirine (J05AR24) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.03. Show package size 30 Index Therapeuticus (Swissmedic) 08.03. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 628.50 Limitation No Deductible 10 % Consumer price 699.95 Feedback FB GTIN 7680670660013 Medication Code Synthetika Pharmacode 7761661 Disponibility
Composition doravirinum 100 mg, lamivudinum 300 mg, tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili fumaras 300 mg, hypromellosi acetas succinas, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, natrii stearylis fumaras, Überzug: hypromellosum, lactosum monohydricum 8.58 mg, triacetinum, cera carnauba, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.22 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Doravirinum 100 mg Lamivudine 300 mg Tenofovir Disoproxil 245 mg
BAG: Active Agent Dose Doravirinum 100 mg Lamivudine 300 mg Tenofovir Disoproxil 245 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum Cera Carnauba E 171 color. E 172 color. Hypromellosi Acetas Succinas Hypromellosum Überzug Lactose Monohydrate 8.58 mg Magnesii Stearas Natrii Stearylis Fumaras Pro Compresso Obducto Silica Colloidalis Anhydrica Triacetinum
Source Data was imported : 19.11.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
